InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by BERRY DAVID A, Director. Director active across 1 company, notably Omega Therapeutics, Inc.. In total, 2 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €1.5m. History available since 3 August 2021. The latest transaction was disclosed on 3 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
David A. Berry is a Board Member of Omega Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide valuable advice to the board. He is committed to supporting the objectives of Omega Therapeutics.